Natural killer cell regulation - Beyond the receptors

F1000Prime Reports

Volumn 6, Issue , 2014, Pages

  Watzl, Carsten ^a   Urlaub, Doris ^a   Fasbender, Frank ^a   Claus, Maren ^a  

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR6; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR; STAT4 PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL SUBPOPULATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTOPENIA; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; REGULATORY MECHANISM; T LYMPHOCYTE; TRANSFORMED CELL; UPREGULATION;

EID: 84908232227     PISSN: 20517599     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P6-87     Document Type: Article

References (117)

1. Herberman RB, Nunn ME, Holden HT, Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 1975, 16:230-9.
2. Herberman RB, Nunn ME, Lavrin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 1975, 16:216-29.
3. Kiessling R, Klein E, Pross H, Wigzell H: "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975, 5:117-21.
4. Kiessling R, Klein E, Wigzell H: "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975, 5:112-7.
5. Peter HH, Kalden JR, Seeland P, Diehl V, Eckert G: Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells. Clin Exp Immunol 1975, 20:193-207.
6. Jost S, Altfeld M: Control of human viral infections by natural killer cells. Annu Rev Immunol 2013, 31:163-94.
7. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S: Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 2013, 31:227-58.
8. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S: Functions of natural killer cells. Nat Immunol 2008, 9:503-10.
9. Watzl C, Urlaub D: Molecular mechanisms of natural killer cell regulation. Front Biosci (Landmark Ed) 2012, 17:1418-32.
10. Orange JS: Natural killer cell deficiency. J Allergy Clin Immunol 2013, 132:515-25; quiz 526.
11. Kärre K, Ljunggren HG, Piontek G, Kiessling R: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986, 319:675-8.
12. Ljunggren HG, Kärre K: Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 1985, 162:1745-59.
13. Karlhofer FM, Ribaudo RK, Yokoyama WM: MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992, 358:66-70.
14. Yokoyama WM, Seaman WE: The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993, 11:613-35.
15. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO: Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995, 2:439-49.
16. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO: Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995, 3:801-9.
17. Colonna M, Navarro F, Bellón T, Llano M, García P, Samaridis J, Angman L, Cella M, López-Botet M: A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997, 186:1809-18.
18. D'Andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL: Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol 1995, 155:2306-10.
19. Colonna M, Samaridis J: Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995, 268:405-8.
20. Long EO: Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999, 17:875-904.
21. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L: Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001, 19:197-223.
22. Lanier LL: Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008, 9:495-502.
23. Vivier E, Nunès JA, Vély F: Natural killer cell signaling pathways. Science 2004, 306:1517-9.
24. Gasser S, Raulet DH: Activation and self-tolerance of natural killer cells. Immunol Rev 2006, 214:130-42.
25. Watzl C, Long EO: Signal transduction during activation and inhibition of natural killer cells. Curr Protoc Immunol 2010, Chapter 11:Unit 11.9B.
26. Raulet DH, Held W, Correa I, Dorfman JR, Wu MF, Corral L: Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 1997, 155:41-52.
27. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P: Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997, 7:739-51.
28. Höglund P, Ohlén C, Carbone E, Franksson L, Ljunggren HG, Latour A, Koller B, Kärre K: Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. Proc Natl Acad Sci USA 1991, 88:10332-6.
29. Zimmer J, Donato L, Hanau D, Cazenave JP, Tongio MM, Moretta A, de la Salle, H: Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med 1998, 187:117-22.
30. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH: A subset of natural killer cells achieves selftolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005, 105:4416-23.
31. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song Y, Yang L, French AR, Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM: Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005, 436:709-13.
32. Anfossi N, André P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagné F, Ugolini S, Vivier E: Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-42.
33. Yokoyama WM, Kim S: Licensing of natural killer cells by selfmajor histocompatibility complex class I. Immunol Rev 2006, 214:143-54.
34. Raulet DH, Vance RE: Self-tolerance of natural killer cells. Nat Rev Immunol 2006, 6:520-31.
35. Brodin P, Lakshmikanth T, Johansson S, Kärre K, Höglund P: The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood 2009, 113:2434-41.
36. Joncker NT, Fernandez NC, Treiner E, Vivier E, Raulet DH: NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J Immunol 2009, 182:4572-80.
37. Brodin P, Kärre K, Höglund P: NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol 2009, 30:143-9.
38. Elliott JM, Yokoyama WM: Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol 2011, 32:364-72.
39. Höglund P, Brodin P: Current perspectives of natural killer cell education by MHC class I molecules. Nat Rev Immunol 2010, 10:724-34.
40. Sun JC, Lanier LL: Tolerance of NK cells encountering their viral ligand during development. J Exp Med 2008, 205:1819-28.
41. Tripathy SK, Keyel PA, Yang L, Pingel JT, Cheng TP, Schneeberger A, Yokoyama WM: Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J Exp Med 2008, 205:1829-41.
42. Orr MT, Lanier LL: Natural killer cell education and tolerance. Cell 2010, 142:847-56.
43. Elliott JM, Wahle JA, Yokoyama WM: MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp Med 2010, 207:2073-9.
44. Joncker NT, Shifrin N, Delebecque F, Raulet DH: Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med 2010, 207:2065-72.
45. Juelke K, Killig M, Thiel A, Dong J, Romagnani C: Education of hyporesponsive NK cells by cytokines. Eur J Immunol 2009, 39:2548-55.
46. Haas P, Loiseau P, Tamouza R, Cayuela J, Moins-Teisserenc H, Busson M, Henry G, Falk CS, Charron D, Socié G, Toubert A, Dulphy N: NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation. Blood 2011, 117:1021-9.
47. Held W, Mariuzza RA: Cis interactions of immunoreceptors with MHC and non-MHC ligands. Nat Rev Immunol 2008, 8:269-78.
48. Bessoles S, Angelov GS, Back J, Leclercq G, Vivier E, Held W: Education of murine NK cells requires both cis and trans recognition of MHC class I molecules. J Immunol 2013, 191: 5044-51.
49. Chalifour A, Scarpellino L, Back J, Brodin P, Devèvre E, Gros F, Lévy F, Leclercq G, Höglund P, Beermann F, Held W: A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 2009, 30:337-47.
50. Jonsson AH, Yang L, Kim S, Taffner SM, Yokoyama WM: Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J Immunol 2010, 184:3424-32.
51. Ebihara T, Jonsson AH, Yokoyama WM: Natural killer cell licensing in mice with inducible expression of MHC class I. Proc Natl Acad Sci USA 2013, 110:E4232-7.
52. Orr MT, Murphy WJ, Lanier LL: 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol 2010, 11:321-7.
53. Tarek N, Le Luduec J, Gallagher MM, Zheng J, Venstrom JM, Chamberlain E, Modak S, Heller G, Dupont B, Cheung NV, Hsu KC: Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. J Clin Invest 2012, 122:3260-70.
54. Guia S, Jaeger BN, Piatek S, Mailfert S, Trombik T, Fenis A, Chevrier N, Walzer T, Kerdiles YM, Marguet D, Vivier E, Ugolini S: Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Sci Signal 2011, 4:ra21.
55. Watzl C, Long EO: Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J Exp Med 2003, 197:77-85.
56. Thomas LM, Peterson ME, Long EO: Cutting edge: NK cell licensing modulates adhesion to target cells. J Immunol 2013, 191:3981-5.
57. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH: The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986, 136:4480-6.
58. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA: Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001, 97:3146-51.
59. Jacobs R, Hintzen G, Kemper A, Beul K, Kempf S, Behrens G, Sykora KW, Schmidt RE: CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol 2001, 31:3121-7.
60. Yu J, Mao HC, Wei M, Hughes T, Zhang J, Park I, Liu S, McClory S, Marcucci G, Trotta R, Caligiuri MA: CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood 2010, 115:274-81.
61. Juelke K, Killig M, Luetke-Eversloh M, Parente E, Gruen J, Morandi B, Ferlazzo G, Thiel A, Schmitt-Knosalla I, Romagnani C: CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells. Blood 2010, 116:1299-307.
62. Lopez-Vergès S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, Norris PJ, Nixon DF, Lanier LL: CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 2010, 116:3865-74.
63. Björkström NK, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson MA, Björklund AT, Flodström-Tullberg M, Michaëlsson J, Rottenberg ME, Guzmán CA, Ljunggren H, Malmberg K: Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010, 116:3853-64.
64. Béziat V, Descours B, Parizot C, Debré P, Vieillard V: NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE 2010, 5:e11966.
65. Chan A, Hong D, Atzberger A, Kollnberger S, Filer AD, Buckley CD, McMichael A, Enver T, Bowness P: CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol 2007, 179:89-94.
66. Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A, Corcuff E, Mortier E, Jacques Y, Spits H, Di Santo, James P: IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 2009, 206:25-34.
67. Romagnani C, Juelke K, Falco M, Morandi B, D'Agostino A, Costa R, Ratto G, Forte G, Carrega P, Lui G, Conte R, Strowig T, Moretta A, Münz C, Thiel A, Moretta L, Ferlazzo G: CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 2007, 178:4947-55.
68. Nagler A, Lanier LL, Cwirla S, Phillips JH: Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989, 143:3183-91.
69. Ellis TM, Fisher RI: Functional heterogeneity of Leu 19"bright"+ and Leu 19"dim"+ lymphokine-activated killer cells. J Immunol 1989, 142:2949-54.
70. Fauriat C, Long EO, Ljunggren H, Bryceson YT: Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 2010, 115:2167-76.
71. Luetke-Eversloh M, Cicek BB, Siracusa F, Thom JT, Hamann A, Frischbutter S, Baumgrass R, Chang H, Thiel A, Dong J, Romagnani C: NK cells gain higher IFN-g competence during terminal differentiation. Eur J Immunol 2014, 44:2074-84.
72. Horowitz A, Strauss-Albee DM, Leipold M, Kubo J, Nemat-Gorgani N, Dogan OC, Dekker CL, Mackey S, Maecker H, Swan GE, Davis MM, Norman PJ, Guethlein LA, Desai M, Parham P, Blish CA: Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med 2013, 5:208ra145.
73. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S: Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331:44-9.
74. Min-Oo G, Kamimura Y, Hendricks DW, Nabekura T, Lanier LL: Natural killer cells: walking three paths down memory lane. Trends Immunol 2013, 34:251-8.
75. Rölle A, Pollmann J, Cerwenka A: Memory of infections: an emerging role for natural killer cells. PLoS Pathog 2013, 9:e1003548.
76. Sun JC, Ugolini S, Vivier E: Immunological memory within the innate immune system. EMBO J 2014, 33:1295-303.
77. O'Leary JG, Goodarzi M, Drayton DL, von Andrian, Ulrich H: T celland B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006, 7:507-16.
78. Paust S, Gill HS, Wang B, Flynn MP, Moseman EA, Senman B, Szczepanik M, Telenti A, Askenase PW, Compans RW, von Andrian, Ulrich H: Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 2010, 11:1127-35.
79. Peng H, Jiang X, Chen Y, Sojka DK, Wei H, Gao X, Sun R, Yokoyama WM, Tian Z: Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest 2013, 123:1444-56.
80. Sun JC, Beilke JN, Lanier LL: Adaptive immune features of natural killer cells. Nature 2009, 457:557-61.
81. Nabekura T, Kanaya M, Shibuya A, Fu G, Gascoigne, Nicholas RJ, Lanier LL: Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity 2014, 40:225-34.
82. Sun JC, Madera S, Bezman NA, Beilke JN, Kaplan MH, Lanier LL: Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J Exp Med 2012, 209:947-54.
83. Firth MA, Madera S, Beaulieu AM, Gasteiger G, Castillo EF, Schluns KS, Kubo M, Rothman PB, Vivier E, Sun JC: Nfil3-independent lineage maintenance and antiviral response of natural killer cells. J Exp Med 2013, 210:2981-90.
84. Beaulieu AM, Zawislak CL, Nakayama T, Sun JC: The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection. Nat Immunol 2014, 15:546-53.
85. Min-Oo G, Bezman NA, Madera S, Sun JC, Lanier LL: Proapoptotic Bim regulates antigen-specific NK cell contraction and the generation of the memory NK cell pool after cytomegalovirus infection. J Exp Med 2014, 211:1289-96.
86. Gumá M, Angulo A, Vilches C, Gómez-Lozano N, Malats N, López- Botet M: Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004, 104:3664-71.
87. Gumá M, Budt M, Sáez A, Brckalo T, Hengel H, Angulo A, López-Botet M: Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006, 107:3624-31.
88. Della Chiesa M, Falco M, Bertaina A, Muccio L, Alicata C, Frassoni F, Locatelli F, Moretta L, Moretta A: Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood. J Immunol 2014, 192:1471-9.
89. Björkström NK, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M, Michaëlsson J, Malmberg K, Klingström J, Ahlm C, Ljunggren H: Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 2011, 208:13-21.
90. Brunetta E, Fogli M, Varchetta S, Bozzo L, Hudspeth KL, Marcenaro E, Moretta A, Mavilio D: Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. AIDS 2010, 24:27-34.
91. Béziat V, Dalgard O, Asselah T, Halfon P, Bedossa P, Boudifa A, Hervier B, Theodorou I, Martinot M, Debré P, Björkström NK, Malmberg K, Marcellin P, Vieillard V: CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol 2012, 42:447-57.
92. +NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci USA 2011, 108:14725-32.
93. Hendricks DW, Balfour HH, Dunmire SK, Schmeling DO, Hogquist KA, Lanier LL: Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus. J Immunol 2014, 192:4492-6.
94. Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM: Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci USA 2009, 106:1915-9.
95. Romee R, Schneider SE, Leong JW, Chase JM, Keppel CR, Sullivan RP, Cooper MA, Fehniger TA: Cytokine activation induces human memory-like NK cells. Blood 2012, 120:4751-60.
96. Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A: Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J Exp Med 2012, 209:2351-65.
97. Chijioke O, Münz C: Dendritic cell derived cytokines in human natural killer cell differentiation and activation. Front Immunol 2013, 4:365.
98. Cui Y, Yang X, Zhu W, Li J, Wu X, Pang Y: Immune response, clinical outcome and safety of dendritic cell vaccine in combination with cytokine-induced killer cell therapy in cancer patients. Oncol Lett 2013, 6:537-41.
99. Lehmann D, Spanholtz J, Sturtzel C, Tordoir M, Schlechta B, Groenewegen D, Hofer E: IL-12 directs further maturation of ex vivo differentiated NK cells with improved therapeutic potential. PLoS ONE 2014, 9:e87131.
100. Hwang I, Zhang T, Scott JM, Kim AR, Lee T, Kakarla T, Kim A, Sunwoo JB, Kim S: Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions. Int Immunol 2012, 24:793-802.
101. Zhang T, Scott JM, Hwang I, Kim S: Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRγ deficiency. J Immunol 2013, 190:1402-6.
102. Sun JC, Beilke JN, Bezman NA, Lanier LL: Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J Exp Med 2011, 208:357-68.
103. Prlic M, Blazar BR, Farrar MA, Jameson SC: In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med 2003, 197:967-76.
104. Jamieson AM, Isnard P, Dorfman JR, Coles MC, Raulet DH: Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J Immunol 2004, 172:864-70.
105. Ranson T, Vosshenrich, Christian AJ, Corcuff E, Richard O, Müller W, Di Santo, James P: IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 2003, 101:4887-93.
106. Majewska-Szczepanik M, Paust S, von Andrian, Ulrich H, Askenase PW, Szczepanik M: Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-α, interferon-γ and interleukin-12. Immunology 2013, 140:98-110.
107. Leong JW, Chase JM, Romee R, Schneider SE, Sullivan RP, Cooper MA, Fehniger TA: Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells. Biol Blood Marrow Transplant 2014, 20:463-73.
108. Lee S, Fragoso MF, Biron CA: Cutting edge: a novel mechanism bridging innate and adaptive immunity: IL-12 induction of CD25 to form high-affinity IL-2 receptors on NK cells. J Immunol 2012, 189:2712-6.
109. Bezman NA, Kim CC, Sun JC, Min-Oo G, Hendricks DW, Kamimura Y, Best JA, Goldrath AW, Lanier LL: Molecular definition of the identity and activation of natural killer cells. Nat Immunol 2012, 13:1000-9.
110. Zawislak CL, Beaulieu AM, Loeb GB, Karo J, Canner D, Bezman NA, Lanier LL, Rudensky AY, Sun JC: Stage-specific regulation of natural killer cell homeostasis and response against viral infection by microRNA-155. Proc Natl Acad Sci USA 2013, 110:6967-72.
111. Sullivan RP, Leong JW, Fehniger TA: MicroRNA regulation of natural killer cells. Front Immunol 2013, 4:44.
112. Trotta R, Chen L, Ciarlariello D, Josyula S, Mao C, Costinean S, Yu L, Butchar JP, Tridandapani S, Croce CM, Caligiuri MA: miR-155 regulates IFN-γ production in natural killer cells. Blood 2012, 119:3478-85.
113. Zediak VP, Wherry EJ, Berger SL: The contribution of epigenetic memory to immunologic memory. Curr Opin Genet Dev 2011, 21:154-9.
114. Weng N, Araki Y, Subedi K: The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation. Nat Rev Immunol 2012, 12:306-15.
115. Cichocki F, Miller JS, Anderson SK, Bryceson YT: Epigenetic regulation of NK cell differentiation and effector functions. Front Immunol 2013, 4:55.
116. Gillard GO, Bivas-Benita M, Hovav A, Grandpre LE, Panas MW, Seaman MS, Haynes BF, Letvin NL: Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes. PLoS Pathog 2011, 7:e1002141.
117. Tong L, Assenmacher M, Zänker KS, Jähn P: Virus-specific peptide dependent NK cell cytotoxicity. Inflamm Allergy Drug Targets 2014, 13:128-33.